These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 24949857)

  • 1. Helicobacter pylori-related diffuse large B-cell lymphoma of the stomach: a distinct entity with lower aggressiveness and higher chemosensitivity.
    Kuo SH; Yeh KH; Chen LT; Lin CW; Hsu PN; Hsu C; Wu MS; Tzeng YS; Tsai HJ; Wang HP; Cheng AL
    Blood Cancer J; 2014 Jun; 4(6):e220. PubMed ID: 24949857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expressions of the CagA protein and CagA-signaling molecules predict Helicobacter pylori dependence of early-stage gastric DLBCL.
    Kuo SH; Chen LT; Lin CW; Yeh KH; Shun CT; Tzeng YS; Liou JM; Wu MS; Hsu PN; Cheng AL
    Blood; 2017 Jan; 129(2):188-198. PubMed ID: 27864293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Helicobacter pylori and gastric lymphoma: high seroprevalence of CagA in diffuse large B-cell lymphoma but not in low-grade lymphoma of mucosa-associated lymphoid tissue type.
    Delchier JC; Lamarque D; Levy M; Tkoub EM; Copie-Bergman C; Deforges L; Chaumette MT; Haioun C
    Am J Gastroenterol; 2001 Aug; 96(8):2324-8. PubMed ID: 11513169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of ZEB1 by miR-200 characterizes Helicobacter pylori-positive gastric diffuse large B-cell lymphoma with a less aggressive behavior.
    Huang WT; Kuo SH; Cheng AL; Lin CW
    Mod Pathol; 2014 Aug; 27(8):1116-25. PubMed ID: 24390222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Helicobacter pylori eradication therapy is effective in the treatment of early-stage H pylori-positive gastric diffuse large B-cell lymphomas.
    Kuo SH; Yeh KH; Wu MS; Lin CW; Hsu PN; Wang HP; Chen LT; Cheng AL
    Blood; 2012 May; 119(21):4838-44; quiz 5057. PubMed ID: 22403257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Helicobacter pylori and mucosa-associated lymphoid tissue: what's new.
    Kuo SH; Cheng AL
    Hematology Am Soc Hematol Educ Program; 2013; 2013():109-17. PubMed ID: 24319171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Helicobacter pylori eradication in gastric diffuse large B cell lymphoma.
    Paydas S
    World J Gastroenterol; 2015 Apr; 21(13):3773-6. PubMed ID: 25852262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Helicobacter pylori-associated gastric lymphoma in a girl.
    Sharon N; Kenet G; Toren A; Mandel M; Neumann Y; Kaplinsky C; Schiby G; Rechavi G
    Pediatr Hematol Oncol; 1997; 14(2):177-80. PubMed ID: 9089746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High grade B-cell gastric lymphoma with complete pathologic remission after eradication of Helicobacter pylori infection: report of a case and review of the literature.
    Cavanna L; Pagani R; Seghini P; Zangrandi A; Paties C
    World J Surg Oncol; 2008 Mar; 6():35. PubMed ID: 18353178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A retrospective analysis of primary gastric diffuse large B-cell lymphoma with or without concomitant mucosa-associated lymphoid tissue (MALT) lymphoma components.
    Li X; Xia B; Guo S; Zhan Z; Zhang L; Zhao D; Wu X; Zhang Y
    Ann Hematol; 2013 Jun; 92(6):807-15. PubMed ID: 23417758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of Helicobacter pylori eradication in the treatment of diffuse large B-cell and marginal zone lymphomas of the stomach.
    Ferreri AJ; Govi S; Ponzoni M
    Curr Opin Oncol; 2013 Sep; 25(5):470-9. PubMed ID: 23942292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B cell receptor signaling related to resistance to Helicobacter pylori eradication therapy in gastric diffuse large B cell lymphoma.
    Torisu T; Kawano S; Miyawaki K; Yamamoto H; Ihara Y; Matsuno Y; Torisu K; Sugio T; Sasaki K; Shimakawa T; Kato K; Akashi K; Nakamura S; Kitazono T
    Hematol Oncol; 2021 Feb; 39(1):145-147. PubMed ID: 33034903
    [No Abstract]   [Full Text] [Related]  

  • 13. Differential response to H. pylori eradication therapy of co-existing diffuse large B-cell lymphoma and MALT lymphoma of stomach-significance of tumour cell clonality and BCL10 expression.
    Kuo SH; Chen LT; Wu MS; Kuo KT; Yeh KH; Doong SL; Yeh PY; Hsu HC; Tzeng YS; Lin CW; Lin JT; Cheng AL
    J Pathol; 2007 Feb; 211(3):296-304. PubMed ID: 17167822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. De-escalating therapy in gastric aggressive lymphoma.
    Cuccurullo R; Govi S; Ferreri AJ
    World J Gastroenterol; 2014 Jul; 20(27):8993-7. PubMed ID: 25083073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Helicobacter pylori (HP) infection alone, but not HP-induced atrophic gastritis, increases the risk of gastric lymphoma: a case-control study in Japan.
    Ishikura N; Usui Y; Ito H; Kasugai Y; Oze I; Kato S; Yatabe Y; Nakamura S; Matsuo K
    Ann Hematol; 2019 Aug; 98(8):1981-1987. PubMed ID: 31177299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of B cell-activating factor of TNF family (BAFF) is associated with Helicobacter pylori-independent growth of gastric diffuse large B-cell lymphoma with histologic evidence of MALT lymphoma.
    Kuo SH; Yeh PY; Chen LT; Wu MS; Lin CW; Yeh KH; Tzeng YS; Chen JY; Hsu PN; Lin JT; Cheng AL
    Blood; 2008 Oct; 112(7):2927-34. PubMed ID: 18628489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Complete remission of diffuse large B-cell lymphoma of the stomach after eradication of Helicobacter pylori].
    Høeg RT; Skau AM; Nørgaard P; Hansen PB
    Ugeskr Laeger; 2011 Sep; 173(39):2425-6. PubMed ID: 21958489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Relationship between Helicobacter pylori infection and expression of connexin (Cx) 32 and Cx43 genes in gastric cancer and gastric precancerous lesions].
    Xu CX; Jia Y; Yang WB; Wang F; Shen SR
    Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(22):1523-7. PubMed ID: 18956631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Helicobacter pylori eradication as exclusive treatment for limited-stage gastric diffuse large B-cell lymphoma: results of a multicenter phase 2 trial.
    Ferreri AJ; Govi S; Raderer M; Mulè A; Andriani A; Caracciolo D; Devizzi L; Ilariucci F; Luminari S; Viale E; Müllauer L; Dell'Oro S; Arcidiacono PG; Ponzoni M; Patti C
    Blood; 2012 Nov; 120(18):3858-60. PubMed ID: 23118214
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of the Clinicopathological Characteristics and Genetic Alterations Between Patients with Gastric Cancer with or Without
    Fang WL; Huang KH; Chang SC; Lin CH; Chen MH; Chao Y; Lo SS; Li AF; Wu CW; Shyr YM
    Oncologist; 2019 Sep; 24(9):e845-e853. PubMed ID: 30796154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.